Liver Cancer
Hepatocellular carcinoma (HCC) is a primary form of liver cancer that typically arises in individuals with chronic liver disease, such as cirrhosis. It can lead to serious health issues and requires prompt medical attention.
Advanced Liver Cancer: CT 01 and Everolimus Study
We are investigating whether CT 01 is safe to use alone or with Everolimus for patients with inoperable advanced liver cancer. This study aims to understand the safety of these treatment options.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Leon Berard
Medical Oncology
Meyzieu, France
Centre Hospitalier Universitaire De Nantes
Hepato-gastroenterology
Nantes, France
Oncopole Claudius Regaud
Medical Digestive Oncology
Portet-sur-Garonne, France
Sponsor: Captor Therapeutics S.A.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.